Physician profile
Drayton Graham
NPI 1356483861
$5,717.26
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,881 · 2020: $1,024 · 2021: $1,248 · 2022: $1,215 · 2023: $103 · 2024: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,746.73 | 2019-2022 | |
| Glaxosmithkline, LLC. | $1,407.66 | 2019-2024 | Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,042.17 | 2019-2022 | |
| Genzyme Corporation | $299.99 | 2021-2022 | |
| Genentech USA, INC. | $197.38 | 2019 | |
| Mylan Specialty L.P. | $161.57 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $133.53 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $108.27 | 2020-2022 | |
| Kestra Medical Technology Services, INC. | $102.94 | 2023 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $96.95 | 2022 | |
| Advanced Respiratory, INC | $82.14 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $79.74 | 2021-2022 | |
| Lilly USA, LLC | $72.67 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $45.63 | 2019-2022 | |
| Intuitive Surgical, INC. | $43.53 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $29.06 | 2019 | |
| La Jolla Pharmaceutical Company | $26.79 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $25.71 | 2021 | |
| Sanofi Pasteur INC. | $14.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drayton Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.